ホーム › 肺がん › イリノイ州

イリノイ州における肺がんの臨床試験

イリノイ州内の拠点で、肺がんに関する62件の研究が参加者を募集しています。

イリノイ州内の都市

公式研究テキスト（英語）

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Rush-Copley Medical Center, Aurora
Advocate Good Shepherd Hospital, Barrington
Illinois CancerCare-Bloomington, Bloomington
他42件

被験者募集中第3相

18歳以上 · 全性別 · 2026/10/02更新 · NCT04267848

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

OSF Saint Anthony's Health Center, Alton
Rush-Copley Medical Center, Aurora
Advocate Outpatient Center - Aurora, Aurora
他54件

被験者募集中観察研究健康なボランティア歓迎

40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069

A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)

University of Illinois Hospital & Health Sciences System ( Site 0044), Chicago

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/10/01更新 · NCT07286149

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

University of Illinois Cancer Center, Chicago

被験者募集中第2相

18歳以上 · 全性別 · 2026/10/01更新 · NCT06172478

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

Rush-Copley Medical Center, Aurora
Advocate Outpatient Center - Aurora, Aurora
Advocate Good Shepherd Hospital, Barrington
他25件

被験者募集中第3相

70歳以上 · 全性別 · 2026/10/01更新 · NCT06096844

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Rush-Copley Medical Center, Aurora
Illinois CancerCare-Bloomington, Bloomington
Illinois CancerCare-Canton, Canton
他35件

被験者募集中第3相

18歳以上 · 全性別 · 2026/10/01更新 · NCT04181060

Empathic Communication Skills (ECS) Training

Advocate Health Care Network, Libertyville

被験者募集中健康なボランティア歓迎

18歳〜100歳 · 全性別 · 2026/10/01更新 · NCT05456841

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Northwestern University, Chicago
Northwestern Medicine Cancer Center Kishwaukee, DeKalb
Northwestern Medicine Cancer Center Delnor, Geneva
他7件

被験者募集中第3相

18歳以上 · 全性別 · 2026/10/01更新 · NCT06498635

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

University of Illinois Cancer Center, Chicago
Center for Care and Discovery, Chicago

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/29更新 · NCT06881784

Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer

Hope and Healing Clinical Research, Hinsdale
Hope and Healing Clinical Research, New Lenox

被験者募集中第2相

18歳以上 · 全性別 · 2026/09/28更新 · NCT07476287

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

North Shore University Health System ( Site 4014), Evanston
Accellacare of Duly ( Site 4005), Lisle

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/25更新 · NCT06312137

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Illinois CancerCare - Bloomington, Bloomington
University of Illinois Hospital and Health Sciences System (Outpatient Cancer Center), Chicago
University of Illinois Hospital and Health Sciences System, Chicago
他10件

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/25更新 · NCT07222566

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

University of Illinois Chicago, Chicago
Illinois Cancer Specialists, Niles

被験者募集中第3相

18歳〜100歳 · 全性別 · 2026/09/25更新 · NCT05920356

Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC

Hope and Healing Clinical Research, Hinsdale
Hope and Healing Clinical Research, New Lenox

被験者募集中第2相

18歳以上 · 全性別 · 2026/09/25更新 · NCT07489066

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

Endeavor Health, Elmhurst
Hope and Healing Cancer Services, Hinsdale
Advocate Medical Group - Libertyville Oncology, Libertyville
他4件

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/25更新 · NCT06758401

A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

Rush University Medical Center, Chicago
University of Illinois Chicago, Chicago

被験者募集中第2相

18歳以上 · 全性別 · 2026/09/25更新 · NCT07154290

A Registry for People With Lung Cancer

Rush University Medical Center (Data collection only), Chicago
Endeavor Health, Evanston

被験者募集中観察研究

18歳以上 · 全性別 · 2026/09/24更新 · NCT06424327

A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion

Local Institution - 0605, Decatur

被験者募集中第2/3相

18歳以上 · 全性別 · 2026/09/23更新 · NCT07063745

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

Research Site, Chicago

被験者募集中第2相

18歳〜95歳 · 全性別 · 2026/09/23更新 · NCT05061550

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

Rush University Medical Center, Chicago

被験者募集中第2/3相

18歳以上 · 全性別 · 2026/09/22更新 · NCT07100080

Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

University of Chicago Comprehensive Cancer Center, Chicago
UC Comprehensive Cancer Center at Silver Cross, New Lenox
University of Chicago Medicine-Orland Park, Orland Park

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/09/17更新 · NCT06287775

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

University of Illinois Cancer Center, Chicago
University of Chicago Medicine, Chicago
City of Hope - Chicago, Zion

被験者募集中第1相

18歳以上 · 全性別 · 2026/09/10更新 · NCT06293898

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Affiliated Oncologists, LLC, Chicago Ridge
City of Hope® Cancer Center Chicago, Zion

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/08更新 · NCT06793215

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

University of Illinois at Chicago, Chicago
University of Chicago Hospital, Chicago
Springfield Clinic Main Campus, Springfield

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/08更新 · NCT06119581

A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors

University of Chicago, New Lenox

被験者募集中第1相

18歳以上 · 全性別 · 2026/09/08更新 · NCT06561685

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

OSF Saint Francis Medical Center, Peoria

被験者募集中第1相

18歳以上 · 全性別 · 2026/09/03更新 · NCT06343402

Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

Illinois Cancer Specialists, Arlington Heights
University of Illinois Hospital and Health Sciences Systems, Chicago

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/01更新 · NCT07185997

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

Illinois Cancer Specialists, Niles

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/01更新 · NCT06712355

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

Alton Memorial Hospital, Alton
Northwestern University, Chicago
Northwestern Medicine Cancer Center Kishwaukee, DeKalb
他3件

被験者募集中第3相

18歳以上 · 全性別 · 2026/08/17更新 · NCT06500481

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Rush-Copley Medical Center, Aurora
Advocate Outpatient Center - Aurora, Aurora
Advocate Good Shepherd Hospital, Barrington
他46件

被験者募集中第3相

18歳以上 · 全性別 · 2026/08/17更新 · NCT05624996

Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors

St. Francis Medical Center (OSF Healthcare), Peoria

被験者募集中第1相

18歳以上 · 全性別 · 2026/08/05更新 · NCT07444814

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

Xencor Investigative Site, Chicago
Xencor Investigative Site, Chicago

被験者募集中第1相

18歳以上 · 全性別 · 2026/08/03更新 · NCT05433142

Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.

Captain James A. Lovell Federal Health Care Center, North Chicago

被験者募集中

50歳〜80歳 · 全性別 · 2026/07/16更新 · NCT07168993

CARE Tool Study Aim 3

Alton Memorial Hospital, Alton

被験者募集中

18歳以上 · 全性別 · 2026/07/08更新 · NCT07296887

Integrated Cancer Repository for Cancer Research

Rush-Copley Cancer Care Center, Aurora
Rush-Copley Healthcare Center, Yorkville

被験者募集中観察研究健康なボランティア歓迎

19歳〜110歳 · 全性別 · 2026/06/29更新 · NCT02012699

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

Advocate Aurora Health, Park Ridge

被験者募集中第2相

18歳〜70歳 · 全性別 · 2026/06/26更新 · NCT04614103

A Study Evaluating The Combination of Immunotherapy With Radiotherapy in Non-Small Cell Lung Cancer

o University of Chicago Medicine Comprehensive Cancer Center, Chicago

被験者募集中第2相

18歳以上 · 全性別 · 2026/06/16更新 · NCT07603856

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Advocate Good Shepherd Hospital, Barrington
Illinois CancerCare-Bloomington, Bloomington
Illinois CancerCare-Canton, Canton
他47件

被験者募集中第2相

18歳以上 · 全性別 · 2026/06/03更新 · NCT05642572

Stereotactic Body Radiation Therapy Planning With Artificial Intelligence-Directed Dose Recommendation for Treatment of Primary or Metastatic Lung Tumors, RAD-AI Study

Northwestern University, Chicago

被験者募集中

18歳以上 · 全性別 · 2026/05/29更新 · NCT05802186

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

University of Chicago, Chicago

被験者募集中第1/2相

12歳以上 · 全性別 · 2026/05/27更新 · NCT03093116

ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。